Neil W. DeLapp

Potent antagonism of 5-HT3 and 5-HT6 receptors by olanzapine

Frank P. Bymaster, Julie F. Falcone, Delbert Bauzon et al. · European Journal of Pharmacology · 2001 · 122 citations

Potent Antagonism, Medicine, Psychopharmacology +6

The Minimum Significant Ratio: A Statistical Parameter to Characterize the Reproducibility of Potency Estimates from Concentration-Response Assays and Estimation by Replicate-Experiment Studies

Brian J. Eastwood, Mark W. Farmen, Philip W. Iversen et al. · SLAS DISCOVERY · 2006 · 122 citations · Full text

Determination of [35S]Guanosine-5′-O-(3-thio)Triphosphate Binding Mediated by Cholinergic Muscarinic Receptors in Membranes from Chinese Hamster Ovary Cells and Rat Striatum Using an Anti-G Protein Scintillation Proximity Assay

Neil W. DeLapp, Jamie H. McKinzie, Barry D. Sawyer et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 117 citations

Xanomeline: A selective muscarinic agonist for the treatment of Alzheimer's disease

Frank P. Bymaster, Celia A. Whitesitt, Harlan E. Shannon et al. · Drug Development Research · 1997 · 104 citations

Neurochemical Biomarkers, Pharmacotherapy, Experimental Pharmacology +19

Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats

Benny Bang‐Andersen, Ben Grayson, F.P. Bymaster et al. · The International Journal of Neuropsychopharmacology · 2010 · 103 citations · Full text